Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 48 (RPS2P48) is a processed pseudogene in the human genome related to the canonical ribosomal protein S2 (RPS2) gene[2][5][6]. Processed pseudogenes arise from retrotransposition events, where mRNA is reverse-transcribed and inserted back into the genome, lacking regulatory elements and usually containing sequence frame disruptions or truncations that make them non-functional[5][6]. RPS2P48 does not encode a protein, is not expressed or translated, and therefore does not have biological function, therapeutic relevance, or disease association. In summary: RPS2P48 is not a functional molecular target, but a non-coding processed pseudogene derived from the ribosomal protein S2 gene and should not be considered a receptor, enzyme, or therapeutic target of any kind[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 48 (RPS2P48).